A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.
Article Details
- CitationCopy to clipboard
Rashdan S, Gerber DE
A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.
Transl Cancer Res. 2017 Feb;6(Suppl 1):S78-S82. doi: 10.21037/tcr.2017.02.12.
- PubMed ID
- 28680831 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs